These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Vitreous fluorophotometry and changes in blood-retinal barrier permeability induced by bendazac lysine.
    Author: Nuzzi G, Venturini I, De Gregorio M, Arsenio L, Maraini G.
    Journal: Acta Ophthalmol Scand; 1997 Feb; 75(1):41-3. PubMed ID: 9088399.
    Abstract:
    Vitreous fluorophotometry was used to investigate the effect of Bendazac lysine on the blood retinal barrier in 12 insulin-dependent diabetics with mild background retinopathy. The study was a randomized, double blind, cross-over trial, drug versus Placebo. Each treatment period was of 4 months. The vitreous penetration coefficient was reduced by 21% (95% c.i. 12, 30; p = 0.001) by treatment with respect to Placebo.
    [Abstract] [Full Text] [Related] [New Search]